^
Association details:
| Biomarker: | PD-L2 overexpression |
|---|---|
| Cancer: | Acute Myelogenous Leukemia |
| Drug: | Bavencio (avelumab) (PD-L1 inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Single-Cell Mass Cytometry Identifies Mechanisms of Resistance to Immunotherapy in AML
Published date:
11/06/2019
Excerpt:
...we did observe high PD-L2 protein expression in AML cells resistant (the 7 with progressive disease) to HMA/PD-L1 inhibition...
Secondary therapy:
azacitidine
DOI:
10.1182/blood-2019-128601
